• Home
  • Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population.

Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population.

Author List
van Kempen BJ, Ferket BS, Steyerberg EW, Max W, Myriam Hunink MG, Fleischmann KE
Publication
International journal of cardiology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1196920
Publication Year
2015
PubMed ID
26547049
Publication Title
van Kempen BJ, Ferket BS, Steyerberg EW, Max W, Myriam Hunink MG, Fleischmann KE. Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population. Int J Cardiol. 2016 Jan 15; 203:422-31.